Star Imaging And Path Lab (BOM:544482) Stock Based Compensation: ₹0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544482 Star Imaging And Path Lab Ltd BOM:544482
22 GF Score
Price ₹83.28
View Full Analysis

What is Star Imaging And Path Lab Stock Based Compensation?

Star Imaging And Path Lab BOM:544482 -2.82% 22 Stock Based Compensation is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:544482 with a GF Score™ of 22/100.

Star Imaging And Path Lab's Stock Based Compensation for the six months ended in Mar. 2026 was ₹0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.

Star Imaging And Path Lab Stock Based Compensation Related Terms

Star Imaging And Path Lab Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Star Imaging And Path Lab's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Star Imaging And Path Lab Stock Based Compensation Chart

Star Imaging And Path Lab Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Stock Based Compensation
0.00 0.00 0.00 0.00 0.00

Star Imaging And Path Lab Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Stock Based Compensation Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
BOM:544482
22GF Score
Star Imaging And Path Lab Ltd BOM:544482
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Star Imaging And Path Lab Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

What does a Stock Based Compensation of ₹0.0 Mil mean?
Star Imaging And Path Lab (BOM:544482) has a Stock Based Compensation of ₹0.0 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Star Imaging And Path Lab and its competitors.
Is Star Imaging And Path Lab's Stock Based Compensation too high?
Star Imaging And Path Lab's current Stock Based Compensation is ₹0.0 Mil. Overall, Star Imaging And Path Lab has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Star Imaging And Path Lab's Stock Based Compensation compare to TMO and DHR?
Star Imaging And Path Lab's Stock Based Compensation of ₹0.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Medical Diagnostics & Research company?
A good Stock Based Compensation depends on the Medical Diagnostics & Research industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Star Imaging And Path Lab and its competitors. Star Imaging And Path Lab's current Stock Based Compensation is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Star Imaging And Path Lab stock overvalued right now?
Star Imaging And Path Lab (BOM:544482) has a current Stock Based Compensation of ₹0.0 Mil. The current Stock Based Compensation is ₹0.0 Mil. Star Imaging And Path Lab's overall GF Score™ is 22/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Star Imaging And Path Lab (BOM:544482), the current Stock Based Compensation is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Star Imaging And Path Lab Business Description

Address 4B/3, Tilak Nagar, Second Floor, West Delhi, Delhi, IND, 110018
Star Imaging And Path Lab Ltd operates a diagnostic testing network, NABL accredited, delivering pathology, radiology, Cardiology, and Neurology services in Delhi and Uttar Pradesh. It offers a comprehensive range of diagnostic imaging services and clinical laboratory tests, including both routine and specialized studies and profiles. These services are essential for the prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. The company's diagnostic imaging and radiology services encompass X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, ultrasounds, bone mineral densitometry, and mammography.
22GF Score

Get the complete analysis for BOM:544482

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹83.28
Price